Can Trade Agreements Cure Pharma-ceutical Ills?
In a paper released today by the Macdonald Laurier Institute, Laura and I examine the issue of intellectual property commitments in free trade agreements. In Canada’s negotiations with the European Union and in the Trans-Pacific Partnership, we face complex and difficult choices regarding pharmaceutical IP reform. The challenge is how to achieve a successful conclusion to [...]










